Skip to main content

Table 1 Baseline characteristics of all elderly COVID-19 patients

From: Correlation of CT-derived pectoralis muscle status and COVID-19 induced lung injury in elderly patients

Characteristics

All patients (N = 116)

Low PMI (n = 39)

Normal PMI (n = 77)

p value

Age

69(65,74)

71(66,75)

68(65,72)

0.041

Male

40(34.5)

14(35.9)

26(33.8)

0.820

BMI

24.2(22.5,26.9)

23.8(21.6,26.0)

24.9(22.7,27.1)

0.124

Current smoking

25(21.6)

15(38.5)

10(13.0)

0.002

Clinical severity score

   

0.543

 Common

113(97.4)

37(94.9)

76(98.7)

 

 Severe

3(2.6)

2(5.1)

1(1.3)

 

 Days from T0 to T1 (days)

5(3,8)

6(3,8)

5(2,7)

0.025

Having underlying medical conditions

 Hypertension

56(48.3)

21(53.8)

35(45.5)

0.435

 Diabetes

25(21.6)

8(20.5)

17(22.1)

0.846

 Coronary heart disease

5(4.3)

2(5.1)

3(3.9)

1

 COPD/asthma

10(8.6)

4(10.3)

6(7.8)

0.731

 CKD

2(1.7)

0(0)

2(2.6)

0.550

 Carcinoma history

11(9.5)

5(12.8)

6(7.8)

0.591

Vaccination status

   

0.485

 Unvaccinated

60(51.7)

16(41)

23(29.9)

 

 Partially vaccinated

39(33.6)

5(12.8)

12(15.6)

 

 Fully vaccinated

17(14.7)

18(46.2)

42(54.5)

 

 Time from illness onset to hospitalization (days)

4(2,5.75)

4(2,5)

4(2,6)

0.894

 Length of stay (days)

26(20.25,29)

26(21,29)

26(20,29)

0.684

 Clinical syndrome score

17.5(12,28)

34(30,38)

16(11,23)

 < 0.001

 Fever

86(74.1)

30(76.9)

56(72.7)

0.626

 Cough

102(87.9)

37(94.9)

65(84.4)

0.183

 Shortness of breath

23(19.8)

7(17.9)

16(20.8)

0.718

 Nausea or vomiting

28(24.1)

17(43.6)

11(14.3)

0.001

 Abdominal pain or diarrhea

41(35.3)

15(38.5)

26(33.8)

0.617

 Loss of smell or taste

13(11.2)

6(15.4)

7(9.1)

0.482

 Stuffy nose or runny nose

28(24.1)

17(43.6)

11(14.3)

0.001

 Headache or dizziness

13(11.2)

8(20.5)

5(6.5)

0.051

 Fatigue

89(76.7)

34(87.2)

55(71.4)

0.058

 Pharyngeal discomfort

36(31.0)

19(48.7)

17(22.1)

0.003

Medical drugs

 Traditional Chinese medicine

116(100)

39(100)

77(100)

1

 Immunoglobulin

8(6.9)

3(7.7)

5(6.5)

1

 Glucocorticoid

1(0.9)

0(0)

1(1.3)

1

 Any antibiotics

13(11.2)

11(28.2)

2(2.6)

 < 0.001

 Any antivirals

41(35.3)

14(35.9)

27(35.1)

0.929

 Neutralizing antibodies

6(5.2)

3(7.7)

3(3.9)

0.402

 Anticoagulant

105(90.5)

37(94.9)

68(88.3)

0.330

  1. Data are the median (interquartile range) or number of patients (percentage) unless otherwise indicated. Clinical syndrome score, the sum of each symptom duration days